Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Leukemia & Lymphoma|April 7, 2016
Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignanciesGrazyna Lipowska-Bhalla, Ester Fagnano, Timothy M Illidge, et al.Expert Opinion on Biological Therapy|April 18, 2015
Immuno-regulatory antibodies for the treatment of cancerJamie Honeychurch, Eleanor J Cheadle, Simon J Dovedi, et al.Immunological Reviews|December 17, 2013
CAR T cells: driving the road from the laboratory to the clinicEleanor J Cheadle, Hannah Gornall, Vania Baldan, et al.British Journal of Haematology|April 22, 2005
Killing of non-Hodgkin lymphoma cells by autologous CD19 engineered T cellsEleanor J Cheadle, David E Gilham, Fiona C Thistlethwaite, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Eradication of established B-cell lymphoma by CD19-specific murine T cells is dependent on host lymphopenic environment and can be mediated by CD4+ and CD8+ T cellsEleanor J Cheadle, Robert E Hawkins, Hayley Batha, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2010
Natural expression of the CD19 antigen impacts the long-term engraftment but not antitumor activity of CD19-specific engineered T cellsEleanor J Cheadle, Robert E Hawkins, Hayley Batha, et al.Cancer Immunology, Immunotherapy : CII|July 25, 2018
Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cellsGemma L Owens, Marcus J Price, Eleanor J Cheadle, et al.Blood|February 23, 2012
Antibody-induced nonapoptotic cell death in human lymphoma and leukemia cells is mediated through a novel reactive oxygen species-dependent pathwayJamie Honeychurch, Waleed Alduaij, Mahsa Azizyan, et al.Cancer Immunology Research|June 1, 2016
Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T CellsSimon J Dovedi, Grazyna Lipowska-Bhalla, Stephen A Beers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Eotaxin-2 and colorectal cancer: a potential target for immune therapyEleanor J Cheadle, Kallingal Riyad, Daren Subar, et al.Pageof 7